Colorado Court Of Appeals Rules For Privacy Rights In Embryo Dispute
By Ellen Trachman,
Above the Law
| 06. 29. 2022
Photo by Tingey Injury Law Firm on Unsplash
Author’s note: the Olsen and Rooks opinions use the term “pre-embryo.” Here, I use the more colloquial term “embryo” — but mean “pre-embryo” or a fertilized egg not transferred or implanted into a human reproductive tract.
The first baby born from an in vitro fertilization (IVF) procedure is now 44 years old. We’ve had over four decades to decide what embryos are, legally speaking, and how to resolve disputes over their control and use. Unfortunately, that analysis has yet to become simple or easy. As a recent Colorado case demonstrates, the attempt to fairly balance the parties’ interests in a fight over embryos is difficult, to say the least. And the shockwaves of the U.S. Supreme Court’s decision in the Dobbs case — overturning Roe and Casey — is likely to muddy the waters even further.
On June 23, 2022, the Colorado Court of Appeals issued an important ruling in the case of In re Marriage of Olsen. This was not this case’s first visit to the Centennial State’s Court...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...